The extra-nuclear interactome of the estrogen receptors: implications for physiological functionsMOLECULAR AND CELLULAR ENDOCRINOLOGYIF3.62021-12-0123PREAI
Strategies to degrade estrogen receptor α in primary and ESR1 mutant-expressing metastatic breast cancerMOLECULAR AND CELLULAR ENDOCRINOLOGYIF3.62019-01-0126PREAI
In silico screening for ER down modulators identifies thioridazine as an anti-proliferative agent in primary, 4OH-tamoxifen-resistant and Y537S ER-expressing breast cancer cellsCELLULAR ONCOLOGYIF4.82018-09-0416OAAI
A functional drug re-purposing screening identifies carfilzomib as a drug preventing 17β-estradiol: ERα signaling and cell proliferation in breast cancer cellsMOLECULAR AND CELLULAR ENDOCRINOLOGYIF3.62018-01-0116OAAI
Emetine induces estrogen receptor alpha degradation and prevents 17β-estradiol-induced breast cancer cell proliferationCELLULAR ONCOLOGYIF4.82017-03-2924PREAI
Dynamin II is required for 17β-estradiol signaling and autophagy-based ERα degradationSCIENTIFIC REPORTSIF3.92016-03-2437OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向